Shaea Alkahtani

Has grant

king saud university
Country flagSaudi Arabia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

International Scientific Partnership Program

Open Date:

Close Date:

Grant: Close

Research Group

Open Date:

Close Date:

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Objectives: Hypertension is common in Alzheimer’s disease (AD) and contributes to functional decline. While ACE inhibitors are widely used for hypertension, their systemic effects on intestinal permeability and physical capacity in AD patients remain unclear. Materials and Methods: We investigated the potential contribution of increased intestinal permeability to handgrip strength (HGS) and physical capacity in patients with Alzheimer’s disease (AD) taking ACE inhibitors. We investigated hypertensive AD patients taking ACE inhibitors (n = 55) or other anti-hypertensive medications (n = 57) at baseline and one year later, along with age-matched controls (n = 64) and normotensive AD patients (n = 61). We measured plasma zonulin, a marker of intestinal permeability, and HGS, and performed the short physical performance battery (SPPB). Results: AD patients had lower HGS, gait speed, SPPB, and higher plasma zonulin than controls at baseline (all p < 0.05). The use of ACE inhibitors was associated with increased HGS and gait speed, and reduced plasma zonulin in AD patients. Conversely, AD patients on other anti-hypertensive medications had higher zonulin and lower HGS but no change in gait speed and SPPB after one year. The patients taking ACE inhibitors also exhibited significant dynamic correlations of zonulin with HGS, gait speed, and SPPB (p < 0.05). ACE inhibitors also reduced plasma C-reactive proteins and 8-isoprostanes as markers of oxidative stress and inflammation. Conclusions: ACE inhibitors may improve physical performance and cognitive function in hypertensive AD patients, primarily through vascular smooth muscle modulation, leading to better perfusion. These effects may indirectly support intestinal barrier and muscle function, highlighting a novel gut–vascular–muscle interface relevant to therapeutic strategies.

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (10)

Terry Boyle

University of South Australia

AUSTRALIA
View details

M. Azhar Hussain

Professor

Roskilde University

DENMARK
View details

Saad Mohammad Alsaad

Associate Professor

king saud university

SAUDI ARABIA
View details

Derrick Bennett

Professor

University of Oxford

UNITED KINGDOM
View details

Firdos Ahmad

Associatet Professor

university of sharjah

UNITED ARAB EMIRATES
View details

Asima Karim

Associate Professor

university of sharjah

UNITED ARAB EMIRATES
View details

Sandra Haider

-

AUSTRIA
View details

Matthew Mclaughlin

University of Western Australia

AUSTRALIA
View details

Maha H. Alhussain

Professor

king saud university

SAUDI ARABIA
View details

Rizwan Qaisar

Associate Professor

university of sharjah

UNITED ARAB EMIRATES
View details